Equities researchers at William Blair issued their FY2025 EPS estimates for VSE in a research note issued on Monday, January 27th. William Blair analyst L. Dipalma anticipates that the construction ...
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.
William Blair downgraded Charles River (CRL) to Market Perform from Outperform without a price target “There is simply too much working against Charles River in the near term to make the stock ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 2.08% of ...
Some results have been hidden because they may be inaccessible to you